Skip to main content

https://phescreening.blog.gov.uk/2017/08/30/diabetic-eye-screening-is-exactly-the-same-for-people-who-have-rarer-forms-of-diabetes/

Diabetic eye screening is exactly the same for people who have rarer forms of diabetes

Posted by: and , Posted on: - Categories: NHS Diabetic Eye Screening Programme

The NHS Diabetic Eye Screening Programme (DES) helps prevent sight loss in people with diabetes. Screening can detect diabetic retinopathy early, when treatment is effective at reducing or preventing damage from the condition.

Most people have heard of Type 1 and Type 2 diabetes. We (the PHE Screening national team) also receive regular queries about some much rarer forms of diabetes, particularly maturity onset diabetes of the young, or MODY for short.

MODY runs strongly in families. It is caused by a mutation (or change) in a single gene. If a parent has this mutation, any child they have will have a 50% chance of inheriting it from them.

The diabetic eye screening test
The diabetic eye screening test and pathway is exactly the same for people who have rarer forms of the disease, such as MODY

Experts estimate that only 1 to 2% of people with diabetes in the UK (20,000 to 40,000 people) have MODY.  As it is so rare, doctors may not be aware of it, so it’s estimated that about 90% of people with MODY are initially mistakenly diagnosed with Type 1 or Type 2 diabetes.

There are 6 different types of MODY and the rates of complications vary across these different types. Most patients don’t know what type of MODY they have.

MODY type Monogenic (single gene) cause Complications and features
MODY-1 HNF-4α Diabetes deteriorates.

Complications as common as with Type 2 diabetes

MODY-2 Glucokinase defect (heterozygotic) Approximately  20% of all MODY.

Mild hyperglycaemia.

Non-progressive form of diabetes.

Complications mild or none.

MODY-3 HNF-1α Commonest of the MODY gene defects, accounting for around 60% of cases.

Responds well to low dose sulphonylurea.

MODY-4 IPF-1 Very rare
MODY-5 HNF-1β May present with renal disease
MODY-x Monogenic, but target unidentified Not known

We aim to offer screening to everyone aged 12 and over identified with diabetes in England. That is around 3 million people.

The national screening programme is highly standardised, routinely quality assured and is not set up to provide highly specialised care for very small groups of people. Therefore, all patients with MODY should be invited for routine diabetic eye screening irrespective of their MODY type.

More information about MODY is available from Diabetes UK.

PHE Screening blogs

PHE Screening BLOGs provide up to date news from all NHS screening programmes.

You can register to receive updates direct to your inbox, so there’s no need to keep checking for new blogs.

Sharing and comments

Share this page